News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

BioPharm Executive - Career Track
Novartis AG (NVS)'s Pharma Head Exits as Drug Business is Split into Two 5/24/2016
Theranos COO Abruptly Resigns, Company Adds New Board Members 5/17/2016
Valeant (VRX)'s New CEO Criticized By Man Who Succeeded Him at Perrigo (PRGO) 5/13/2016
Endo Pharma (ENDP) to Cut 740 Employees and Shakes Up U.S. Senior Management in Restructuring 5/9/2016
Clovis Oncology (CLVS) to Eliminate 35% of Workforce and Ends All Trials of Lung Cancer Drug Rociletinib 5/9/2016
Valeant (VRX) Close to Naming Perrigo (PRGO)'s Joseph Papa as New CEO 4/22/2016
Osiris (OSIR) Fires CMO Jon Hopper 4/18/2016
Investors Assure Pfizer (PFE)’s Ian Read: We Have Your Back 4/8/2016
ImmunoGen (IMGN) CEO to Retire, Successor to be Named Soon 4/5/2016
Ousted Hemispherx (HEB) CEO Files Lawsuit, Seeks $1 Million+ Wages and Bonuses He's Allegedly Owes 4/1/2016
Gilead (GILD) Lost Top Cancer Scientist Right Before Zydelig Troubles Hit 3/30/2016
Valeant (VRX) Hunts for a New CEO, Blames Former CFO Schiller for Recent Financial Misstatements 3/21/2016
GlaxoSmithKline (GSK) CEO Sir Andrew Witty to Step Down in 2017 3/17/2016
Investigation Finds Ex-Provectus CEO Did Not Produce Travel Documentation, May Have Altered Receipts 3/16/2016
Illumina (ILMN) CEO Stepping Down After 17 Years 3/8/2016
Bayer (BAY) Strategy Head Expected to be Named CEO Next Week 2/22/2016
Gilead (GILD)’s New CEO, John Milligan, Hints at Probable Mergers and Acquisitions 2/18/2016
Former Google (GOOG) Exec to Take Helm at San Francisco Diagnostic Firm Grail 2/11/2016
Pfizer (PFE) Announces Merger Structure and Top Executive Team 2/11/2016
Amidst Allegations of Financial Misconduct, Osiris (OSIR) CEO Resigns 2/5/2016
Sanofi (SNY) Rumored to Announce Job Cuts in U.S. Before Feb. 9 1/27/2016
Apple (AAPL) Ramps Up its Medtech Workforce 1/18/2016
Biogen (BIIB) CMO Says Company Plans To Hire 150 For Neuroscience Development 1/18/2016
Baxalta (BXLT)'s CEO Hantson to Leave After Merger With Shire (SHPG) is Complete 1/13/2016
Celgene (CELG) Juggles Executive Leadership Amid Volatile Stock Prices, New CEO Named 1/13/2016
Theranos' Elizabeth Holmes Hints at Sexism in Media Coverage 12/14/2015
Alnylam (ALNY)'s Human Resources Boss Provides Hiring Strategy, Planning to Hire 1,500 By 2020 12/11/2015
Chase Pharma Taps Former Allergan (AGN) Exec as CEO 12/3/2015
With Former GlaxoSmithKline (GSK) Cancer Chief at Its Helm, Kesios Therapeutics Locks In $28.5 Million 12/2/2015
Biotech's Bad Boy Martin Shkreli Named CEO of KaloBios (KBIO) 11/24/2015
CEO Steps Down from Struggling MannKind Corporation (MNKD) 11/20/2015
Embattled Valeant (VRX) to Offer Cash and Stock to Keep Anxious U.S. Employees 11/19/2015
Retired Genzyme Chief Takes Over Board Leadership Responsibilities at AVEO Oncology (AVEO) 11/9/2015
As Biogen (BIIB) Cuts 11% of Staff, Company Doubles Down on Clinical Trials 11/6/2015
Google (GOOG)'s Life Science Spinoffs Attract Superstar Scientists 10/27/2015
Prominent Fund Manager Urges GlaxoSmithKline (GSK) to Break Up 10/27/2015
In Face of Dropping Stocks and Failed Phase III, Biogen (BIIB) Restructures, Slashes Programs and Lays off 880 People 10/23/2015
Perrigo (PRGO) to Chop 800 Jobs, Buy Back Shares to Fend Off Mylan (MYL) 10/22/2015
Turing Pharma CEO Martin Shkreli Taunts Democratic Candidates on Social Media, Still Has Not Lowered Price for Daraprim 10/15/2015
Google (GOOG) Poaches Top Brain Scientist to Lead Mental Health Project 9/17/2015
Merck KGaA (MKGAF.PK) Reorganizes Healthcare Management Team 9/16/2015
Sun Pharma (SUNPHARMA.NS) Appoints David Kaysen as CEO Amidst Equity Activity and Phase I Pancreas Cancer Trials 9/16/2015
Acadia (ACAD) Appoints Steve Davis as CEO 9/3/2015
Some Biotech Execs Get Huge Pay Boosts as VC Money Pours In 9/2/2015
AstraZeneca PLC (AZN) Taps Genentech (RHHBY)’s Sean Bohen as New Chief Medial Officer 8/25/2015
Merck & Co. (MRK) to Slash Another 2,500 Jobs as Part of Company Restructuring 8/20/2015
H. Lundbeck A/S (LUN.CO) Slashing 1,000 Employees as Company Faces Declining Revenue Due to Generic Competition 8/20/2015
Boston Scientific (BSX) Cuts 455 as It Closes Two Facilities; Abbott (ABT) Terminates 244 8/18/2015
23andMe Taps Former Adaptive Biotech Exec as CFO and Head of Ops 8/17/2015
Avalanche Biotech (AAVL) CEO Resigns Amidst Clinical Data Questions and Stock Plummeting 7/24/2015
Biogen (BIIB) R&D Head Jumps Ship to Helm Unnamed Startup 7/13/2015
IMPAX Labs (IPXL) Founder and Ex-CEO Resigns Board Seat 7/7/2015
Sarepta (SRPT) Bags Ex-Genzyme CEO as Advisor to the Company 7/1/2015
Amgen (AMGN) To Lay Off 330 in Colorado as Part of Almost 4,000 Jobs Cuts Overall 6/30/2015
Ex-AstraZeneca PLC (AZN) CMO Takes Helm at Tiny Syndax 6/16/2015
Former Sanofi (SAN.PA) Exec and Viehbacher Protoge to Join Alnylam (ALNY) as Senior VP 6/9/2015
Pfizer (PFE) Split Could Come as Early as 2015-2016, J.P. Morgan Says 6/9/2015
Dow Chemical  (DOW) Defends CEO Who Allegedly Used Company Cash to Fund Vacations, Super Bowl 6/5/2015
Stock Tanks After Market as Regulus (RGLS) CEO Quits Unexpectedly 6/4/2015
200 Jobs Promised at Alexion (ALXN) Amid €450 Million Expansion 5/12/2015
Johnson & Johnson (JNJ) Eyes $300 Million Expansion &100 New Jobs in Florida 5/8/2015
As Hampton Takes Over as Chairman at GlaxoSmithKline (GSK), CEO Witty Needs to Deliver or "Step Aside" 5/6/2015
Novo Nordisk A/S (NVO)'s $225 Million Hemophilia Facility Will Create 100 New Jobs 5/5/2015
Outgoing Ariad (ARIA) CEO Has No Regrets and "Will Work Harder Than Ever" Until a Successor is Named 4/30/2015
Ex-Teva (TEVA) CEO Becomes Chief of Start-Up Ovid Therapeutics As Orphan Drugs Come Into Focus 4/16/2015
Valeant (VRX) Exec's $50.6 Million Paycheck Makes Him the Second Highest Paid Non-CEO Employee 4/14/2015
Amgen (AMGN) CEO Gets $14M Payday, But Colleagues Who Took Pay Cuts May Disagree 4/10/2015
Is Gilead (GILD) CEO Worth The Money? 4/8/2015
Sarepta (SRPT) CEO Resigns Abruptly, Was "In Over His Head" 4/6/2015
Allergan (AGN) CEO Pyott Out But Don't Fret, He May Have Landed His Next Gig Already 3/19/2015
23andMe Dives Into Biotech With Ex-Genentech (RHHBY) R&D Star at Helm 3/18/2015
Acadia (ACAD) Tanks as Key Drug is Delayed, CEO Resigns 3/16/2015
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO 3/5/2015
GlaxoSmithKline (GSK) CEO's Pay Cut by 46% as Profits Decline 3/2/2015
Sanofi (SAN.PA) Officially Names Paris-Educated Brandicourt as New CEO 2/23/2015
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/23/2015
GlaxoSmithKline (GSK) Replaces Head of Struggling U.S. Operations 2/18/2015
Hospira CEO May Walk Away With More Than $80 Million After Pfizer (PFE) Deal is Finalized 2/12/2015
FDA Commissioner to Step Down After Six Years 2/6/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China 1/27/2015
Takeda (TKPYY) COO Was Approached for Sanofi (SAN.PA) CEO Job But Declined 1/23/2015
Ousted Sanofi (SAN.PA) CEO Pockets $5 Million+ Severance Package 1/23/2015
Bristol-Myers Squibb (BMY) Names Caforio As New CEO Effective May 5 1/22/2015
Aegerion (AEGR) Stays Mum as Top Investors Push to Oust CEO, Consider Sale 1/20/2015
Genentech (RHHBY)'s R&D Chief To Retire; Small Molecule Head Takes Over Top Spot 12/16/2014
Ex-Wyeth (WYE) Head Out Of The Running For Sanofi (SAN.PA) CEO Gig 12/15/2014
Regeneron (REGN) CEO Says He's Sticking To Plan To Double NY Workforce, Lauds Funding "Halo" 12/15/2014
Mylan Inc. (MYL) To Pay Five Top Execs $32.5 Million Earlier Than Planned As Drugmaker Exits U.S. 12/11/2014
AstraZeneca PLC (AZN) Will Invest $200M, Add 300 Jobs In Maryland Plant Expansion 11/24/2014
Oxford Pharmaceuticals Plans New U.S. Location With 200 Jobs 11/19/2014
Johnson & Johnson (JNJ)'s McNeil Consumer Healthcare May Shutter 800 Employee Plant 11/6/2014
Amgen (AMGN) Now Expects Job Cuts To Exceed 2,900 10/30/2014
Sanofi (SAN.PA) Approached AstraZeneca PLC (AZN)'s Soriot For CEO Role 10/30/2014
Sanofi (SAN.PA) Mulls Firing CEO Viehbacher 10/29/2014
Amgen (AMGN) Lays Off 274 Employees As Part Of Its Exit From Washington State 10/27/2014
Gilead Sciences, Inc. (GILD) To Create More Than 80 Jobs With $50 Million Expansion 10/23/2014
Ex-Dendreon Corporation (DNDN) CEO Gold Working On New Cancer Drug Startups 10/14/2014
Retrophin (RTRX) Booted CEO For Multiple Stock Violations: Report 10/6/2014
Agilent Technologies Inc. (A) Announces CEO Transition: Mike Mcmullen To Succeed Bill Sullivan In March 2015 9/18/2014
Merck KGaA (MKGAF.PK) Appoints New Deputy Chief As CEO Kley’s Succession Is Pondered 9/18/2014
Google Inc.'s Calico To Hire As Many As 150 Staffers; Some May Be Current Genentech (RHHBY) Employees 9/12/2014
Genzyme Corporation (GENZ) To Move 500-Employees To New Space In Westborough 9/8/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX) 8/20/2014
Boehringer Ingelheim Corporation Goes On A Hiring Freeze And Plans To Chop Jobs 8/14/2014
Handpicked By Ex-CEO, Takeda Pharmaceutical Co. Ltd. (TKPYY)'s New Leader Vows To Remain Japanese-Based, Will Attempt To Get Company Out Of Slump 8/12/2014
More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named 8/1/2014
Merck & Co., Inc. (MRK) Cuts Another 600 Sales Reps 7/25/2014
Sarepta Therapeutics (SRPT) Terminates Chief Science Officer As It Heads Toward Drug Approval 7/25/2014
Eli Lilly and Company (LLY) To Cut Up To 100 Indy Jobs, Send Some Work Overseas 7/23/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
With Boardroom Drama Behind Him, Teva Pharmaceutical Industries Limited (TEVA) Chairman Phillip Frost To Step Down By End Of The Year 6/19/2014
Valeant Pharmaceuticals International (VRX) Senior Executive Leaves Amidst Allergan Inc. (AGN) Takeover Battle 6/17/2014
Booming Moderna Therapeutics, Inc. Doubles Footprint In Cambridge Due To Rapid Growth 6/13/2014
Novo Nordisk A/S (NVO) To Hire 6,000 New Employees In Denmark By 2022 6/13/2014
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014
Organization Changes At Celgene (CELG) Have Got Investors Wondering Who Will Take Over Once Hugin Steps Down 5/23/2014
Alcon Laboratories, Inc. (ACL) Slashes Headcount By 200 5/19/2014
AcelRx Pharmaceuticals (ACRX) Triples Headcount, Expands Bay Area Facility 5/19/2014
Gilead Sciences, Inc. (GILD) Shareholders Decimate Plan To Tie CEO Compensation To Drug Access 5/9/2014
Teva Pharmaceutical Industries Limited (TEVA) To Speed Up Cost-Cutting Plans, Layoffs And Facility Shutdowns On The Horizon 5/7/2014
AstraZeneca PLC (AZN) Investors Enraged, Revolt Over Executive Pay Plans 4/28/2014
Alexion Pharmaceuticals Inc. (ALXN) CEO Racks Up $30 Million Salary In 2013 4/24/2014
Novartis AG (NVS) Deal Makes GlaxoSmithKline (GSK)'s Pennsylvania Staffers Nervous 4/23/2014
AbbVie (ABBV) Moving Up To 2,000 Workers Off Abbott Laboratories (ABT) Campus 4/22/2014
Pfizer Inc. (PFE) CEO Takes On Additional Role, Becomes PhRMA Board Chairman 4/11/2014
Johnson & Johnson (JNJ) Taps Industry's First Tech-Savvy Chief Design Officer 3/21/2014
Entrepreneur Seamus Mulligan Cashes In $86 Million Of Jazz Pharmaceuticals plc (JAZZ) To Fund New Venture 3/21/2014
In Another Top Management Move, Takeda Pharmaceutical Co. Ltd. (TKPYY) Appoints New Emerging Markets Chief 3/20/2014
Indian Firms Warm Up To Ireland, Could Create 1,000 More Jobs 3/19/2014
Gilead Sciences, Inc. (GILD) Chief: $180 Million Man 3/19/2014
Biogen Idec (BIIB) Taps Papadopoulos As Its Chairman, Replacing Young 2/17/2014
Ex-Gilead Sciences, Inc. (GILD) Exec Takes Job At Alexion Pharmaceuticals Inc. (ALXN) In Ireland 2/11/2014
Another 550 AstraZeneca PLC (AZN) Jobs Axed 2/7/2014
Novartis AG (NVS)'s Cost-Cutting Move Affects Up To 4,000 Jobs 2/4/2014
AstraZeneca PLC (AZN) To Shutter Indian R&D Site; To Impact 170 Jobs 1/29/2014
Lexicon Pharmaceuticals, Inc. (LXRX) Axes 45 Percent Of Jobs, CEO To Step Down 1/14/2014
First Gilead Sciences, Inc. (GILD), Now Amgen (AMGN) Loses A Top Exec 1/13/2014
Novartis AG (NVS) Head, Herve Hoppenot, Flys The Coop To Become CEO Of Incyte Corporation (INCY) 1/13/2014
Teva Pharmaceutical Industries Limited (TEVA) Confirms Rumor, Picks Turnaround Specialist As New CEO 1/9/2014
Gilead Sciences, Inc. (GILD)'s Head Of Commercial Operations To Step Down 1/8/2014
Optimer Pharmaceuticals, Inc. (OPTR) Chops 177 New Jersey Staffers 12/6/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY) Names GlaxoSmithKline (GSK) Exec For Top Post 12/3/2013
Forest Laboratories, Inc. (FRX) To Trim Jobs In $500 Million Restructuring 12/2/2013
Eisai Company, Ltd. (ESALY.PK)'s R&D Organization Undergoes "Transformation," Chops 130 Jobs 12/2/2013
Merck & Co. (MRK) To Shutter Irish Plant, 570 Jobs To Go 12/2/2013
Google Inc.'s Calico Snags Big Biotech Names: Ex-Genentech (RHHBY) Exec Barron, Top Scientist Botstein 11/20/2013
Bristol-Myers Squibb Company (BMY) Shakes Up Senior Management Team 11/18/2013
Novartis AG (NVS) to Beef Up Cambridge Site With 175 New Jobs, Slashes 500 R&D Jobs Elsewhere 11/8/2013
Ariad Pharmaceuticals, Inc. (ARIA) Chops 40 Percent of Workforce in the U.S. 11/8/2013
Teva Pharmaceutical Industries Limited (TEVA) CEO Resigns After Reported Feud With Chairman 10/31/2013
Amarin Corporation PLC (AMRN) Slashes Half Its Staff After FDA Panel Scraps Fish-Oil Pill Expansion 10/23/2013
Roche (RHHBY) to Spend $880 Million in Biologics Future; Will Inject $285 Million Into Genentech (RHHBY)'s Vacaville, Oceanside Sites, Create 250 New Jobs 10/15/2013
Teva Pharmaceutical Industries Limited (TEVA) Plans to Cut About 5,000 Employees 10/11/2013
Boehringer Ingelheim Corporation's Ben Venue Laboratories to Shut Down Operations Permanently; 1,100 Staffers Handed Pink Slips 10/7/2013
Merck & Co., Inc. (MRK) Slashes 8,500 Jobs to Save $2.5 Billion 10/2/2013
Forest Laboratories, Inc. (FRX) Names Brent Saunders CEO and President 9/10/2013
Bayer AG (BAYN.DE) to Hire 800 in Russia Over the Next Four Years 9/10/2013
Rigel Pharmaceuticals, Inc. (RIGL) Axes 18 Pct of Workforce, Ends Some Drug Programs 9/6/2013
Onyx Pharmaceuticals, Inc. (ONXX) CEO Could Snag $62 Million if He Leaves After Amgen (AMGN) Takeover 9/5/2013
Newly Named VIVUS, Inc. (VVUS) CEO Resigns Due to Health Concerns, Ex-Johnson & Johnson (JNJ) Exec to Take Over 9/4/2013
Regeneron Pharmaceuticals, Inc. (REGN) Planning to Add 85 Jobs 8/23/2013
Boehringer Mannheim Corporation's Ben Venue Laboratories to Trim Hundreds of Jobs, Will Cut Production Activity by Year's End 8/21/2013
Bill & Melinda Gates Foundation Lures Biotech VC to Work on Global Health Startups 8/15/2013
Lundbeck Inc. (LUN.CO) to Hire More Than 200 Reps to Market Brintellix 8/8/2013
New VIVUS, Inc. (VVUS) CEO to Focus on Retail Push for Diet Pill 8/7/2013
Bristol-Myers Squibb Company (BMY) to Bring 579 New Jobs to FL 7/22/2013
Roche (RHHBY) Takes Its Hunt for a New Chairman Further Afield 7/22/2013
Notice Regarding Transfer of Shares of Eisai Company, Ltd. (ESALY.PK) Subsidiary 7/19/2013
Bitter Pfizer Inc. (PFE) Fight Ends With Ex-Onyx Pharmaceuticals, Inc. (ONXX) Exec as New Chief 7/19/2013
AstraZeneca PLC (AZN) CFO Jumps Ship to BG Group 7/15/2013
Alexion Pharmaceuticals Inc. (ALXN) to Break Ground on $100 Million Headquarters, Will Create 200-300 New Jobs 6/19/2013
AstraZeneca PLC (AZN) Announces New $500 Million Cambridge Biomedical Campus HQ, Will Employ 2000 by 2016 6/19/2013
New Millennium Chief Faces Questions and Uncertainties, Acknowledges Takeda Pharmaceutical Co. Ltd. (TKPYY) Restructuring May Lead to Job Cuts 6/18/2013
GlaxoSmithKline (GSK) Fires Head of Its Chinese R&D Unit for Data Fraud 6/12/2013
The AbbVie (ABBV) Culture Change Continues: 100 Scientists Will be Laid Off 6/3/2013
Forest Laboratories, Inc. (FRX) CEO Solomon Finally Listens to Carl Icahn and Will Retire 5/23/2013
Ranbaxy Laboratories (RANBAXY.BO) Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source 5/23/2013
AstraZeneca PLC (AZN) Closes in on Site for New $500 Million Home in Cambridge 5/22/2013
Third Rock Ventures Taps Alnylam Pharmaceuticals (ALNY) CEO, Genzyme Corporation (GENZ)-ImClone Systems (LLY) Vets, as Venture Partners 5/14/2013
Millennium Pharmaceuticals, Inc. CEO Out as Takeda Pharmaceutical Co. Ltd. (TKPYY) Reorganizes, Cuts Costs 5/13/2013
Fresh on the Market AbbVie (ABBV) Axing Hundreds of Jobs to Deal With Patent Losses 4/16/2013
Eli Lilly and Company (LLY) Plans to Lay Off 30 Pct of Its Sales Reps 4/15/2013
Bristol-Myers Squibb Company (BMY) to Spend $250 Million to Expand Biologics Facility, Increase Workforce by 350 4/11/2013
New Amgen (AMGN) CEO Doubles His Salary in First Year 4/9/2013
Eli Lilly and Company (LLY) to Spend $260 Million on Indianapolis Expansion, Will Hire Hundreds 4/2/2013
AstraZeneca PLC (AZN): 2300 More Layoffs; Global Total Now 5050 3/22/2013
Compensation Jumps 43 Pct for AbbVie (ABBV) CEO 3/19/2013
Affymax, Inc. (AFFY) May File for Bankruptcy; Cuts 75 Pct of Workforce 3/19/2013
Johnson & Johnson (JNJ) Cuts Executive Bonuses, Citing "Disappointments" 3/14/2013
Performance Pay Package Halved for GlaxoSmithKline (GSK) CEO 3/7/2013
Genentech (RHHBY) Expected to Hire 600 New Employees, Bay Area Included 3/4/2013
Teva Pharmaceutical Industries Limited (TEVA) to Sell California Plant as Part of Cost Cutting 2/8/2013
Pfizer Inc. (PFE) Closes Clinical Research Unit in Singapore 2/8/2013
Amgen (AMGN) to Cut 160 Jobs 2/4/2013
AstraZeneca PLC (AZN) Fails to Rule Out Job Cuts as Profits Plunge 2/1/2013
Novartis AG (NVS) Slashes CEO, Chairman Pay; Vasella Steps Down 1/24/2013